Los Angeles Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $233K | Sell |
|
|||||
|
2024
Q3 | $466K | Sell |
|
|||||
|
2024
Q2 | $299K | Buy |
|
|||||
|
2024
Q1 | $457K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $218K | Buy |
|
|||||
|
2023
Q2 | $216K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $264K | Sell |
|
|||||
|
2018
Q4 | $888K | Sell |
|
|||||
|
2018
Q3 | $1.11M | Buy |
|
|||||
|
2018
Q2 | $1.18M | Buy |
|